Filter Results
:
(597)
Show Results For
-
All HBS Web
(1,033)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (385)
Show Results For
-
All HBS Web
(1,033)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (385)
Sort by
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more...
View Details
- 24 May 2011
- First Look
First Look: May 24
decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on...
View Details
Keywords:
Sean Silverthorne
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
including a 20-article investigative series in the New York Times that discovered similar cases at other hospitals. The US Food and Drug Administration (FDA) started investigations of the CT devices, dozens of patients joined in a...
View Details
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,...
View Details
Keywords:
Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from...
View Details
Keywords:
Martha Lagace
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
being in second place, it’s a pretty good place to be.” Consumers end up paying more To study how pricing algorithms affect competition, MacKay and Brown collected detailed pricing data from five large, multicategory retailers selling the same over-the-counter allergy...
View Details
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and...
View Details
Keywords:
Dina Gerdeman
- 29 Oct 2013
- First Look
First Look: October 29
scheme, more extensive than any previously revealed in professional sports history." Until that moment with Oprah, Armstrong had consistently and strenuously denied using performance enhancing drugs (PEDs), blood transfusions, or...
View Details
Keywords:
Sean Silverthorne
- 23 Aug 2016
- First Look
August 23, 2016
particular, we examine how individuals’ prior experiences and the experiences of those around them alter their belief perseverance in operational decisions after the revelation of negative news. We draw on an exogenous announcement of negative news by the Food and...
View Details
Keywords:
Sean Silverthorne
- 12 Feb 2008
- First Look
First Look: February 12, 2007
stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was highly undervalued due to poor management. After gaining board...
View Details
Keywords:
Martha Lagace
- 21 Apr 2009
- First Look
First Look: April 21, 2009
Industry Location Author:Arthur A. Daemmrich Abstract A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a...
View Details
Keywords:
Martha Lagace
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and...
View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
at the US Food and Drug Administration and the Centers for Medicare and Medicaid Services. The pandemic has made it clear that this must change. Richard Hamermesh (@RHamermesh) is a Baker Foundation Professor of Management Practice and...
View Details
Keywords:
by Danielle Kost
- 12 May 2009
- First Look
First Look: May 12, 2009
their practices. Sermo earns revenue by charging clients who would value early information regarding the effectiveness of new drugs and medical devices-investment managers, pharmaceutical companies, and regulatory authorities. Clients...
View Details
Keywords:
Martha Lagace
- 14 Dec 2010
- First Look
First Look: Dec. 14
511-075 By 2009, Hikma Pharmaceuticals operated 13 manufacturing plants in 8 countries of which 5 were approved by the U.S. Food and Drug Administration. Hikma tracked its sales revenues over the period to show from where the largest...
View Details
Keywords:
Sean Silverthorne
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010...
View Details
Keywords:
Sean Silverthorne
- 24 Jul 2007
- First Look
First Look: July 24, 2007
the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. Purchase this case:...
View Details
Keywords:
Martha Lagace
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
with revenue expectations of $1 billion in 2015. At the time of the acquisition, AbbVie received more than 60% of its sales from the drug Humira, a biologic agent used to treat several autoimmune diseases and malignancies. However, Humira...
View Details
Keywords:
Sean Silverthorne